Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 24, 2010 David Meier	Could Qualcomm Be a Multibagger? Strong returns on equity can generate powerful returns for shareholders.
The Motley Fool August 24, 2010 David Meier	Could Bristol-Myers Squibb Be a Multibagger? Strong returns on equity can generate powerful returns for shareholders.
The Motley Fool August 24, 2010 David Meier	Could Alcon Be a Multibagger? Strong returns on equity can generate powerful shareholder returns.
The Motley Fool August 25, 2010 David Meier	Can MedcoHealth Solutions Produce Big Returns? MedcoHealth Solutions generates incredible returns on equity. Let's see how it does it.
The Motley Fool August 24, 2010 David Meier	Can McKesson Produce Big Returns? McKesson uses its production advantage -- high asset turnover and reasonable leverage -- to generate very attractive returns on equity for shareholders.
The Motley Fool August 24, 2010 David Meier	Can TJX Produce Big Returns? TJX uses its production advantage -- low margins, high asset turnover, and reasonable leverage -- to generate very attractive returns on equity for shareholders.
The Motley Fool August 25, 2010 David Meier	Could Medtronic Be a Multibagger? With higher margins than ZOLL Medical and Boston Scientific, Medtronic clearly outshines the competition.
The Motley Fool August 24, 2010 David Meier	Can Express Scripts Produce Big Returns? Express Scripts generates incredible returns on equity. Let's see how they do it.
The Motley Fool August 18, 2010 David Meier	Here's How Apple Creates Its Advantage Use the DuPont formula to identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Target Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Sysco Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How The Home Depot Creates Its Advantage Quickly identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Amazon.com Creates Its Advantage Identify where a company's competitive advantage lies.
The Motley Fool August 18, 2010 David Meier	Here's How Wal-Mart Creates Its Advantage Wal-Mart has used its consumer advantage to generate attractive returns on equity.
The Motley Fool January 18, 2011 Jim Royal	How Do These Biotechs Really Make Their Money? Break it down using the Dupont formula.
The Motley Fool January 19, 2011 Jim Royal	How Do These Oil Companies Really Boost Their Returns? Let's see what the DuPont formula can tell us about Petrobras and a few of its sector and industry peers
The Motley Fool January 18, 2011 Jim Royal	How Do These Oil Companies Really Make Their Money? Break down Exxon-Mobil's and some of its peers' return on investment using the Dupont formula.
The Motley Fool November 30, 2010 Jim Royal	How Do These Software Companies Really Make Their Money? Break it down using the Dupont formula.
The Motley Fool November 30, 2010 Jim Royal	How Do These Consumer Goods Companies Really Make Their Money? Let's take a look at Procter & Gamble and a few of its sector and industry peers using the Dupont Formula.
The Motley Fool January 19, 2011 Jim Royal	How Do These Transports Really Boost Their Returns? UPS and FedEx are well-known rivals, but their returns on equity differ sharply.
The Motley Fool November 12, 2011 Jim Royal	How Does Staples Boost Its Returns? As investors, we need to understand how our companies truly make their money. A neat trick developed for just that purpose - the DuPont Formula - can help us do so.
The Motley Fool August 18, 2011 Shubh Datta	What You Need to Know About Advance Auto Parts' Return on Equity Delving a little deeper into what is driving Advance's Return on Equity.
The Motley Fool January 19, 2011 Jim Royal	How Do These Miners Really Boost Their Returns? Let's take a look at BHP Billiton and a few of its sector and industry peers using the DuPont Formula, to see how they actually make their money.
The Motley Fool January 18, 2011 Jim Royal	How Does Big Pharma Really Make Its Money? As investors, we need to understand how our companies truly make their money. Thankfully, there's a neat trick developed for just that purpose: the DuPont Formula.
The Motley Fool December 30, 2010 Jim Royal	How Do These Beverage Companies Really Make Their Money? Let's use the Dupont formula to get a better grasp on exactly where Coca-Cola and other beverage companies are producing profit and where they might have a competitive advantage.
The Motley Fool August 10, 2010 Matt Koppenheffer	How'd Frontier Communications Get So Profitable? How did Frontier Communications manage to boost its return on equity?
The Motley Fool October 18, 2010 Gerard Torres	Every Investor Should Know This Stock Tool Use DuPont analysis to breakdown the profitability of stocks.
The Motley Fool January 18, 2011 Jim Royal	How Does Big Tobacco Really Make Its Money? Breaking down a company's return on equity can often give you some insight into how it's competing against peers and what type of strategy it's using to juice its return on equity.
The Motley Fool December 30, 2010 Jim Royal	How Do These Telecoms Really Make Their Money? Breaking these telecom companies' returns on equity can give you some insight into how they're competing against peers: AT&T... Vodafone... Verizon... America Movil...
The Motley Fool January 18, 2011 Jim Royal	How Do These High-Yielding REITs Really Make Their Money? Let's take a look at Annaly Capital Management and a few of its sector and industry peers using the DuPont formula to see how they really make their money.
The Motley Fool December 29, 2010 Jim Royal	How Do These Retailers Really Make Their Money? By using the DuPont Formula, you can get a better grasp on exactly where your company is producing its profit and where it might have a competitive advantage. Let's look at Wal-Mart using this criteria.
IndustryWeek August 1, 2005 Traci Purdum	IW 50 Best U.S. Manufacturers -- Methodology The formula factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
IndustryWeek June 1, 2008 Jonathan Katz	IW 50 Best U.S. Manufacturers -- 2008 Methodology The formula to determine the 50 best U.S. manufacturers factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
IndustryWeek June 1, 2006 Traci Purdum	IW 50 Best U.S. Manufacturers -- Methodology To determine the 50 best manufacturers, a formula factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
IndustryWeek June 1, 2007 Traci Purdum	IW 50 Best U.S. Manufacturers -- 2007 Methodology The formula to identify the top performing manufacturers factors in revenue growth, profit margins, return on equity, return on assets and asset turnover, and inventory turns.
The Motley Fool December 8, 2009 Stephen Mauzy	There's More Than One Way to Turn a Buck Many investor focus on margins when asset turnover can generate sufficient profits.
The Motley Fool October 31, 2011 Eric Bleeker	Where Amgen Is Finding Its Growth Five years ago, Amgen collected 83% of its sales from the United States.
The Motley Fool May 23, 2011 Andrew Tonner	Does Amgen Deserve a Spot in Your Portfolio? Depending on your assessment of future growth, Amgen could certainly make a nice addition to your portfolio.
The Motley Fool December 13, 2011	A Brief History of Teva Pharmaceutical's Returns The good news is that, at 15 times earnings, Teva shares now look reasonably valued.
The Motley Fool November 2, 2010 Jeremy Phillips	Time to Sell Amgen? We're seeking danger signs among Fools' most beloved stocks.
The Motley Fool November 28, 2011	A Brief History of Amgen's Returns Amgen shares declined 17% over the past decade. What has happened?
The Motley Fool November 29, 2010 Seth Jayson	Here's How Teva Pharmaceutical May Be Failing You Here's the margin picture for Teva Pharmaceutical over the past few years.
The Motley Fool May 29, 2011 Andrew Tonner	Does Watson Pharmaceuticals Deserve a Spot in Your Portfolio? Although Watson Pharmaceuticals doesn't look like a stock for your portfolio right now, the search doesn't end here.
The Motley Fool April 7, 2010 Rick Steier	Is Teva Pharmaceutical a Forever Hold? Teva is a compelling reason why investors should look abroad for opportunity.
The Motley Fool February 28, 2011 Cindy Johnson	Medicis Pharmaceutical Shares Popped: What You Need to Know Medicis Pharmaceutical Corporation popped 26% in intraday trading today after reporting an inline quarter and announcing a licensing agreement with Teva Pharmaceutical Industries.
The Motley Fool May 24, 2011 Andrew Tonner	Does Eli Lilly Deserve a Spot in Your Portfolio? A quick check of the numbers should help get us started.
Investment Advisor October 2009 Savita Iyer-Ahrestani	About the Manager A short biography of Charles "Chuck" Akre, founder of ACM Capital Management.
The Motley Fool August 1, 2005 Stephen D. Simpson	Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance.
The Motley Fool October 5, 2011 Dan Caplinger	Has Teva Pharmaceutical Become the Perfect Stock? Teva still looks poised to stay near perfection for the indefinite future.
The Motley Fool July 18, 2011 Brian Orelli	A $3.6 Billion Franchise at Stake Amgen and Teva settle their patent dispute, and Amgen investors have a little better idea of when the company's $3.6 billion Neupogen and Neulasta franchise might come under attack in the United States.